1.The Preventive Effects of Dexamethasone and Ondansetron for Postoperative Nausea and Vomiting after Tympanomastoidectomy.
Woo Ri RYU ; Jung Sam LEE ; Jae Young KWON ; Chul Hong KIM ; Hyum Soo JANG
Korean Journal of Anesthesiology 2007;52(5):556-560
BACKGROUND: Postoperative nausea and vomiting (PONV) is the major cause of patient's discomfort after surgery. Dexamethasone and ondansetron have been known to have some preventive effects on PONV. The purpose of this study was to compare the effects combination therapy of these drugs in the prevention of PONV after tympanomastoidectomy which has been known to be a high risk factor of PONV. METHODS: Ninty patients scheduled tympanomastoidectomy under general anesthesia were included. Patients were randomly divided into three groups and received dexamethasone 5 mg (group D), ondansetron 4 mg (group O), or dexamethasone 5 mg plus ondansetron 4 mg (group DO) at 30 min before the end of operation. The degree of PONV was assessed at 6 h, 12 h, 24 h, and 48 h after operation. RESULTS: The degrees of nausea in group DO during 0-6 h and 6-12 h were lesser than those of other groups. The overall incidences of nausea were 73% (group D), 62% (group O), and 23% (group DO, P < 0.05). The degrees of vomiting in group O and DO during 0-6 h were lesser than those of group D. The overall incidences of vomiting were 37% (group D), 17% (group O), and 7% (group DO, P < 0.05). CONCLUSIONS: The combination of dexamethasone and ondansetron is more effective than single use of each drug for the prevention on PONV after tympanomastoidectomy.
Anesthesia, General
;
Dexamethasone*
;
Humans
;
Incidence
;
Nausea
;
Ondansetron*
;
Postoperative Nausea and Vomiting*
;
Risk Factors
;
Vomiting
2.Multiple Metastatic Brain Tumor: Complicated with Post-dural Puncture Headache : A case report.
Sang Ha LEE ; Hyun Soo JANG ; Jung Sam LEE ; Ok Sik HAN ; Woo Ri RYU
Anesthesia and Pain Medicine 2007;2(3):169-171
Epidural blood patch is an effective management for treatment of severe post-dural puncture headache. Here we describe a case of a patient with hip fracture, who was complained regarded as having suspicious post-dural puncture headache after epidural anesthesia, but it failed to be treated with 4 times of epidural blood patch, and later was diagnosed with multiple metastatic brain tumor.
Anesthesia, Epidural
;
Blood Patch, Epidural
;
Brain Neoplasms*
;
Brain*
;
Headache
;
Hip
;
Humans
;
Post-Dural Puncture Headache*
3.A case of cardiac arrest following bupivacaine injection for shoulder arthroscopy : A case report.
Won Ki YOON ; Jung Sam LEE ; Hyun Su JANG ; Young Hoon JO ; Woo Ri RYU
Anesthesia and Pain Medicine 2009;4(1):15-18
Intra-articular administration of local anesthetics such as bupivacaine can produce short-term postoperative analgesia in patients who are undergoing shoulder arthroscopy. Yet bupivacaine can result in cardiovascular toxicity that can lead to cardiac arrest. We experienced a case of 63-year-old male patient with severe cardiac toxicity that led to ventricular fibrillation 15 minutes after injecting 0.5% bupivacaine into the patient's shoulder joint for shoulder arthroscopy.
Analgesia
;
Anesthetics, Local
;
Arthroscopy
;
Bupivacaine
;
Heart Arrest
;
Humans
;
Male
;
Middle Aged
;
Shoulder
;
Shoulder Joint
;
Ventricular Fibrillation
4.A Case of Hepatocellular Carcinoma with Metastasis to Gingival Mucosa.
Soo Jeong CHOI ; Young Seok KIM ; Na Ri KIM ; Soung Won JEONG ; Sun Hae LEE ; Jun Sung JEONG ; Kwon Ho RYU ; Sang Woo CHA ; Su Jin HONG ; Chang Beom RYU ; Jong Ho MOON ; Yun Soo KIM ; Moon Sung LEE ; Chan Sup SHIM ; Boo Sung KIM ; Kye Won KWON ; Byoung Yong KIM
The Korean Journal of Hepatology 2002;8(4):495-499
Hepatocellular carcinoma is one of the most common causes of death in Koreans. Most cases of hepatocellular carcinoma are beyond the stage of curative resection at the time of diagnosis due to extrahepatic metastasis as well as wide distribution of tumor in the liver. The lung is the most common site of extrahepatic metastasis but metastasis to gingiva is very rare in hepatocellular carcinoma. We report a case hepatecellular carcinoma with gingival methststasis in a 59 year old male patient.
Carcinoma, Hepatocellular/*secondary
;
English Abstract
;
Gingival Neoplasms/*secondary
;
Human
;
Liver Neoplasms/*pathology
;
Male
;
Middle Aged
5.Data Resource Profile: The Cancer Public Library Database in South Korea
Dong-Woo CHOI ; Min Yeong GUK ; Hye Ri KIM ; Kwang Sun RYU ; Hyun-Joo KONG ; Hyo Soung CHA ; Hyun-Jin KIM ; Heejung CHAE ; Young Sang JEON ; Hwanhee KIM ; Jipmin JUNG ; Jeong-Soo IM ; Kui Son CHOI
Cancer Research and Treatment 2024;56(4):1014-1026
This paper provides a comprehensive overview of the Cancer Public Library Database (CPLD), established under the Korean Clinical Data Utilization for Research Excellence project (K-CURE). The CPLD links data from four major population-based public sources: the Korea National Cancer Incidence Database in the Korea Central Cancer Registry, cause-of-death data in Statistics Korea, the National Health Information Database in the National Health Insurance Service, and the National Health Insurance Research Database in the Health Insurance Review & Assessment Service. These databases are linked using an encrypted resident registration number. The CPLD, established in 2022 and updated annually, comprises 1,983,499 men and women newly diagnosed with cancer between 2012 and 2019. It contains data on cancer registration and death, demographics, medical claims, general health checkups, and national cancer screening. The most common cancers among men in the CPLD were stomach (16.1%), lung (14.0%), colorectal (13.3%), prostate (9.6%), and liver (9.3%) cancers. The most common cancers among women were thyroid (20.4%), breast (16.6%), colorectal (9.0%), stomach (7.8%), and lung (6.2%) cancers. Among them, 571,285 died between 2012 and 2020 owing to cancer (89.2%) or other causes (10.8%). Upon approval, the CPLD is accessible to researchers through the K-CURE portal. The CPLD is a unique resource for diverse cancer research to investigate medical use before a cancer diagnosis, during initial diagnosis and treatment, and long-term follow-up. This offers expanded insight into healthcare delivery across the cancer continuum, from screening to end-of-life care.
6.Data Resource Profile: The Cancer Public Library Database in South Korea
Dong-Woo CHOI ; Min Yeong GUK ; Hye Ri KIM ; Kwang Sun RYU ; Hyun-Joo KONG ; Hyo Soung CHA ; Hyun-Jin KIM ; Heejung CHAE ; Young Sang JEON ; Hwanhee KIM ; Jipmin JUNG ; Jeong-Soo IM ; Kui Son CHOI
Cancer Research and Treatment 2024;56(4):1014-1026
This paper provides a comprehensive overview of the Cancer Public Library Database (CPLD), established under the Korean Clinical Data Utilization for Research Excellence project (K-CURE). The CPLD links data from four major population-based public sources: the Korea National Cancer Incidence Database in the Korea Central Cancer Registry, cause-of-death data in Statistics Korea, the National Health Information Database in the National Health Insurance Service, and the National Health Insurance Research Database in the Health Insurance Review & Assessment Service. These databases are linked using an encrypted resident registration number. The CPLD, established in 2022 and updated annually, comprises 1,983,499 men and women newly diagnosed with cancer between 2012 and 2019. It contains data on cancer registration and death, demographics, medical claims, general health checkups, and national cancer screening. The most common cancers among men in the CPLD were stomach (16.1%), lung (14.0%), colorectal (13.3%), prostate (9.6%), and liver (9.3%) cancers. The most common cancers among women were thyroid (20.4%), breast (16.6%), colorectal (9.0%), stomach (7.8%), and lung (6.2%) cancers. Among them, 571,285 died between 2012 and 2020 owing to cancer (89.2%) or other causes (10.8%). Upon approval, the CPLD is accessible to researchers through the K-CURE portal. The CPLD is a unique resource for diverse cancer research to investigate medical use before a cancer diagnosis, during initial diagnosis and treatment, and long-term follow-up. This offers expanded insight into healthcare delivery across the cancer continuum, from screening to end-of-life care.
7.Data Resource Profile: The Cancer Public Library Database in South Korea
Dong-Woo CHOI ; Min Yeong GUK ; Hye Ri KIM ; Kwang Sun RYU ; Hyun-Joo KONG ; Hyo Soung CHA ; Hyun-Jin KIM ; Heejung CHAE ; Young Sang JEON ; Hwanhee KIM ; Jipmin JUNG ; Jeong-Soo IM ; Kui Son CHOI
Cancer Research and Treatment 2024;56(4):1014-1026
This paper provides a comprehensive overview of the Cancer Public Library Database (CPLD), established under the Korean Clinical Data Utilization for Research Excellence project (K-CURE). The CPLD links data from four major population-based public sources: the Korea National Cancer Incidence Database in the Korea Central Cancer Registry, cause-of-death data in Statistics Korea, the National Health Information Database in the National Health Insurance Service, and the National Health Insurance Research Database in the Health Insurance Review & Assessment Service. These databases are linked using an encrypted resident registration number. The CPLD, established in 2022 and updated annually, comprises 1,983,499 men and women newly diagnosed with cancer between 2012 and 2019. It contains data on cancer registration and death, demographics, medical claims, general health checkups, and national cancer screening. The most common cancers among men in the CPLD were stomach (16.1%), lung (14.0%), colorectal (13.3%), prostate (9.6%), and liver (9.3%) cancers. The most common cancers among women were thyroid (20.4%), breast (16.6%), colorectal (9.0%), stomach (7.8%), and lung (6.2%) cancers. Among them, 571,285 died between 2012 and 2020 owing to cancer (89.2%) or other causes (10.8%). Upon approval, the CPLD is accessible to researchers through the K-CURE portal. The CPLD is a unique resource for diverse cancer research to investigate medical use before a cancer diagnosis, during initial diagnosis and treatment, and long-term follow-up. This offers expanded insight into healthcare delivery across the cancer continuum, from screening to end-of-life care.
8.Data Resource Profile: The Cancer Public Library Database in South Korea
Dong-Woo CHOI ; Min Yeong GUK ; Hye Ri KIM ; Kwang Sun RYU ; Hyun-Joo KONG ; Hyo Soung CHA ; Hyun-Jin KIM ; Heejung CHAE ; Young Sang JEON ; Hwanhee KIM ; Jipmin JUNG ; Jeong-Soo IM ; Kui Son CHOI
Cancer Research and Treatment 2024;56(4):1014-1026
This paper provides a comprehensive overview of the Cancer Public Library Database (CPLD), established under the Korean Clinical Data Utilization for Research Excellence project (K-CURE). The CPLD links data from four major population-based public sources: the Korea National Cancer Incidence Database in the Korea Central Cancer Registry, cause-of-death data in Statistics Korea, the National Health Information Database in the National Health Insurance Service, and the National Health Insurance Research Database in the Health Insurance Review & Assessment Service. These databases are linked using an encrypted resident registration number. The CPLD, established in 2022 and updated annually, comprises 1,983,499 men and women newly diagnosed with cancer between 2012 and 2019. It contains data on cancer registration and death, demographics, medical claims, general health checkups, and national cancer screening. The most common cancers among men in the CPLD were stomach (16.1%), lung (14.0%), colorectal (13.3%), prostate (9.6%), and liver (9.3%) cancers. The most common cancers among women were thyroid (20.4%), breast (16.6%), colorectal (9.0%), stomach (7.8%), and lung (6.2%) cancers. Among them, 571,285 died between 2012 and 2020 owing to cancer (89.2%) or other causes (10.8%). Upon approval, the CPLD is accessible to researchers through the K-CURE portal. The CPLD is a unique resource for diverse cancer research to investigate medical use before a cancer diagnosis, during initial diagnosis and treatment, and long-term follow-up. This offers expanded insight into healthcare delivery across the cancer continuum, from screening to end-of-life care.
9.Anhedonia and Dysphoria Are Differentially Associated with the Risk of Dementia in the Cognitively Normal Elderly Individuals: A Prospective Cohort Study
Ju Ri LEE ; Seung Wan SUH ; Ji Won HAN ; Seonjeong BYUN ; Soon Jai KWON ; Kyoung Hwan LEE ; Kyung Phil KWAK ; Bong Jo KIM ; Shin Gyeom KIM ; Jeong Lan KIM ; Tae Hui KIM ; Seung Ho RYU ; Seok Woo MOON ; Joon Hyuk PARK ; Dong Woo LEE ; Jong Chul YOUN ; Dong Young LEE ; Seok Bum LEE ; Jung Jae LEE ; Jin Hyeong JHOO ; Ki Woong KIM
Psychiatry Investigation 2019;16(8):575-580
OBJECTIVE: We investigated the impact of depressed mood (dysphoria) and loss of interest or pleasure (anhedonia)on the risk of dementia in cognitively-normal elderly individuals. METHODS: This study included 2,685 cognitively-normal elderly individuals who completed the baseline and 4-year follow-up assessments of the Korean Longitudinal Study on Cognitive Aging and Dementia. We ascertained the presence of dysphoria and anhedonia using the Mini International Neuropsychiatric Inventory. We defined subjective cognitive decline as the presence of subjective cognitive complaints without objective cognitive impairments. We analyzed the association of dysphoria and anhedonia with the risk of cognitive disorders using multinomial logistic regression analysis adjusted for age, sex, education, Cumulative Illness Rating Scale score, Apolipoprotein E genotype, and neuropsychological test performance. RESULTS: During the 4-year follow-up period, anhedonia was associated with an approximately twofold higher risk of mild cognitive impairment (OR=2.09, 95% CI=1.20–3.64, p=0.008) and fivefold higher risk of dementia (OR=5.07, 95% CI=1.44–17.92, p=0.012) but was not associated with the risk of subjective cognitive decline. In contrast, dysphoria was associated with an approximately twofold higher risk of subjective cognitive decline (OR=2.06, 95% CI=1.33–3.19, p=0.001) and 1.7-fold higher risk of mild cognitive impairment (OR=1.75, 95% CI=1.00–3.05, p=0.048) but was not associated with the risk of dementia. CONCLUSION: Anhedonia, but not dysphoria, is a risk factor of dementia in cognitively-normal elderly individuals.
Aged
;
Anhedonia
;
Apolipoproteins
;
Cognition Disorders
;
Cognitive Aging
;
Cohort Studies
;
Dementia
;
Depression
;
Education
;
Follow-Up Studies
;
Genotype
;
Humans
;
Logistic Models
;
Longitudinal Studies
;
Mild Cognitive Impairment
;
Neuropsychological Tests
;
Pleasure
;
Prospective Studies
;
Risk Factors
10.Overview of the Korean Longitudinal Study on Cognitive Aging and Dementia.
Ji Won HAN ; Tae Hui KIM ; Kyung Phil KWAK ; Kayoung KIM ; Bong Jo KIM ; Shin Gyeom KIM ; Jeong Lan KIM ; Tae Hyun KIM ; Seok Woo MOON ; Jae Young PARK ; Joon Hyuk PARK ; Seonjeong BYUN ; Seung Wan SUH ; Ji Young SEO ; Yoonseop SO ; Seung Ho RYU ; Jong Chul YOUN ; Kyoung Hwan LEE ; Dong Young LEE ; Dong Woo LEE ; Seok Bum LEE ; Jung Jae LEE ; Ju Ri LEE ; Hyeon JEONG ; Hyun Ghang JEONG ; Jin Hyeong JHOO ; Kyuhee HAN ; Jong Woo HONG ; Ki Woong KIM
Psychiatry Investigation 2018;15(8):767-774
OBJECTIVE: Due to an unprecedented rate of population aging, South Korea is facing a dementia epidemic. For this reason, the Korean Longitudinal Study on Cognitive Aging and Dementia (KLOSCAD) was launched in 2009 with support from the Korean Health Industry Development Institute to investigate the epidemiology, biopsychosocial risk factors, and outcomes of dementia and dementia-related conditions. METHODS: The KLOSCAD is the first nationwide multi-center population-based prospective cohort study. In October 2010, 12,694 individuals were randomly sampled from residents aged 60 years or older who lived in 13 districts across South Korea. In the baseline assessment, which was conducted from November 2010 through October 2012, 6,818 (53.7%) individuals participated. Follow-up assessments have been conducted every two years, with the first follow-up assessment conducted between November 2012 and October 2014, and the second between November 2014 and October 2016. The third is now in progress, and will span from November 2016 to October 2018. Diagnosis of cognitive disorders, neuropsychological battery, behavioral and psychological symptoms of dementia, activities of daily living, physical and neurologic examination and laboratory tests, life styles, quality of life, and identification of death were evaluated in each assessment. RESULTS: The cumulative drop-out rate at the second follow-up assessment was 38.7%. Dementia and mild cognitive impairment were 5.0% and 27.0%, respectively. CONCLUSION: The KLOSCAD may provide strong scientific evidence for advancing the fight against dementia both in Korea and globally.
Activities of Daily Living
;
Aging
;
Cognitive Aging*
;
Cohort Studies
;
Dementia*
;
Diagnosis
;
Epidemiology
;
Follow-Up Studies
;
Korea
;
Life Style
;
Longitudinal Studies*
;
Mild Cognitive Impairment
;
Neurologic Examination
;
Prospective Studies
;
Quality of Life
;
Risk Factors